In the last trading session, 1.07 million Neuronetics Inc (NASDAQ:STIM) shares changed hands as the company’s beta touched 1.85. With the company’s per share price at $3.46 changed hands at -$0.03 or -0.72% during last session, the market valuation stood at $228.06M. STIM’s last price was a discount, traded about -71.1% off its 52-week high of $5.92. The share price had its 52-week low at $0.52, which suggests the last value was 84.97% up since then. When we look at Neuronetics Inc’s average trading volume, we note the 10-day average is 1.23 million shares, with the 3-month average coming to 869.24K.
Analysts gave the Neuronetics Inc (STIM) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.00. If we narrow down to specifics, the data shows that 0 out of 2 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended STIM as a Hold, 2 felt it is a Buy and 0 rated the stock as Underweight.
Neuronetics Inc (NASDAQ:STIM) trade information
Instantly STIM was in red as seen at the end of in last trading. With action -2.12%, the performance over the past five days has been red. The company’s shares are showing year-to-date upside of 90.38%, with the 5-day performance at -2.12% in the red. However, in the 30-day time frame, Neuronetics Inc (NASDAQ:STIM) is -11.38% down. Looking at the short shares, we see there were 3.11 million shares sold at short interest cover period of 5.27 days.
The consensus price target for the stock as assigned by Wall Street analysts is 8, meaning bulls need an upside of 56.75% from its current market value. According to analyst projections, STIM’s forecast low is 8 with 8 as the target high. To hit the forecast high, the stock’s price needs a -131.21% plunge from its current level, while the stock would need to soar -131.21% for it to hit the projected low.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 2.71%. The 2025 estimates are for Neuronetics Inc earnings to increase by 74.08%.
STIM Dividends
Neuronetics Inc is expected to release its next quarterly earnings report on 2025-May-06.
Neuronetics Inc (NASDAQ:STIM)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 9.17% of Neuronetics Inc shares while 62.80% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 69.15%. There are 62.80% institutions holding the Neuronetics Inc stock share, with ARCHON CAPITAL MANAGEMENT LLC the top institutional holder. As of 2024-06-30, the company held 8.23% of the shares, roughly 2.47 million STIM shares worth $4.45 million.
CANNELL CAPITAL LLC holds the second largest percentage of outstanding shares, with 7.9239% or 2.38 million shares worth $4.29 million as of 2024-06-30.
Among Mutual Funds, the top two as of Mar 31, 2025 were VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund . With 1.81 shares estimated at $6.26 million under it, the former controlled 2.75% of total outstanding shares. On the other hand, VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund held about 0.65% of the shares, roughly 429.32 shares worth around $1.49 million.